Vir Biotechnology (VIR) Leases (2020 - 2026)

Vir Biotechnology's Leases history runs 7 years deep, the most recent figure standing at $60.8 million for Q1 2026.

• In Q1 2026, Leases rose 3.76% year-over-year to $60.8 million; the TTM figure through Mar 2026 stood at $60.8 million (up 3.76% YoY), while the FY2025 annual figure was $62.1 million, up 4.05% from the prior year.
• Leases came in at $60.8 million for Q1 2026 at Vir Biotechnology, down from $62.1 million in the prior quarter.
• In the past five years, Leases ranged from a high of $88.3 million in Q1 2022 to a low of $58.6 million in Q1 2025.
• A 5-year average of $70.9 million and a median of $70.3 million in 2024 frame the typical range for Leases.
• Across the five-year window, Leases jumped 47.32% in 2022 and slipped 16.91% in 2024, its largest moves.
• Vir Biotechnology's Leases stood at $82.6 million in 2022, then fell by 13.78% to $71.2 million in 2023, then decreased by 16.16% to $59.7 million in 2024, then increased by 4.05% to $62.1 million in 2025, then fell by 2.16% to $60.8 million in 2026.
• According to Business Quant data, Leases over the past three periods registered $60.8 million, $62.1 million, and $63.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison